NCT00192153View on ClinicalTrials.gov

Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine(CAIV-T)in Healthy Adults Aged 18 to 59 and Healthy Adults Aged 60 Years and Older

PHASE2CompletedINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

July 31, 2001

Study Completion Date

October 31, 2001

Conditions
Influenza
Interventions
BIOLOGICAL

CAIV-T or TIV

Trial Locations (2)

22908

University of VA Health Sciences Center, Charlottesville

34652

West Coast Medical Associates, New Port Richey

Sponsors

Lead Sponsor

MedImmune LLC
All Listed Sponsors
collaborator

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

lead

MedImmune LLC

INDUSTRY